About 391,400 coronavirus vaccines have been delivered to the city as of Jan. 3, but only 104,910 people have received their first dose. Wafaa Ed-Sadr, MD, MPH, MPA, global director of ICAP, explained that there has been growing pains on how to manage the distribution of the vaccine.
“I think that’s both a resources issue, assistance issue as well as a communications issue,” she said. “We have to be working on all of these fronts at the same time so that we can get as many of these very valuable vaccines into people’s arms as we can.”
A major global health organization that has been improving public health in countries around the world for over 15 years, ICAP works to transform the health of populations through innovation, science, and global collaboration. Based at Columbia University in New York City, where it is part of the Mailman School of Public Health, ICAP has projects in more than 30 countries, working side-by-side with ministries of health and local partners to confront some of the world’s toughest health challenges. Through meaningful research, tailored technical assistance, effective training and education programs, and rigorous surveillance to measure and evaluate the impact of public health interventions, ICAP aims to realize a global vision of healthy people, empowered communities, and thriving societies. Online at icap.columbia.edu